Yep, people look at the business model before they invest... And management kept saying ''next year is the year''.
And then they changed business model out of the blue.
Then they said AKD1000 was not selling. So they got 1500 on.
And akd2 was supposed to be the saviour of us, but yet the so called ''business model'' does not seem to work as yet.
Absolutely agree to the fact that numpties have no clue what's going on....
Look at the above post by the clown dilzy of brainchip.
He seems to be excited about CES 2026 and 2027 while there is absolutely no guarantee that this would any way benefit BRN.
Goal posts have been moved by Brainchip so many times.... I find it hard to believe the suck ups don't see it! Probably had too much grog at the meetings.
Commercialisation was supposed to be a piece of cake for the first mover.
Plenty of companies were queueing up with interest at BRN's expos and roadshows.
What do they have to show for?
Heaps of debt and a couple of IP deals that has sold NO products.
Would be a miracle if the head doesn't hurt.
- Forums
- ASX - By Stock
- BRN
- 2024 BrainChip Discussion
2024 BrainChip Discussion, page-843
-
-
- There are more pages in this discussion • 6,099 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 388739 | 9 |
0.205 | 944687 | 16 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online